Charles River Labs share price logo

Charles River Labs

NYSE: CRL

Large Cap

$273.00

-5.35

(-1.92%)

as on

Charles River Labs Stock Performance

as on September 11, 2026 at 2:15 pm IST

  • Day's Low

    Day's High

    $272.06
    $275.88
    downward going graph

    0.34%

    Downside

    1.05%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $144.26
    $303.31
    downward going graph

    47.16%

    Downside

    11.10%

    Upside

    downward going graph

Charles River Labs share price movements today

Previous Close
$278.35
Open
$273.10
Volume
382.2K
Market Cap
$13.5B
Day's Low - High
$272.06 - $275.88
52 Week Low - High
$144.26 - $303.31

Charles River Labs Historical Returns

1 Month Return
+ 0.49 %
3 Month Return
+ 49.42 %
1 Year Return
+ 81.61 %
3 Year Return
+ 39.36 %
5 Year Return
-36.88 %

Charles River Labs Stock Fundamentals & Key Indicators

Check Charles River Labs market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$13.5B

EPS (TTM)

11.3182

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

-0.17%

PE Ratio (TTM)

0

PEG Ratio

0.1222

EBITDA

849.1M

Revenue (TTM)

4.0B

Profit Margin

-5.96%

Return On Equity TTM

-7.52%

Charles River Labs vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Charles River Labs with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
BUY$13.5B-36.88%NA-5.96%NA
BUY$46.7B174.91%-228.5165.30%NA
BUY$42.2B-1.35%31.6126.23%NA
BUY$226.9B5.9%32.5340.37%29.849999999999998%
BUY$146.0B-37.92%36.2858.51%70.16%

Stock Returns calculator for Charles River Labs Stock including INR - Dollar returns

The Charles River Labs stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Charles River Labs investment value today

Current value as on today

₹1,93,038

Returns

₹93,038

(+93.04%)

Returns from Charles River Labs Stock

₹78,117 (+78.12%)

Dollar Impact

₹14,921 (+14.92%)

Analyst Recommendation on Charles River Labs Stock

Based on 12 analysts

BUY

83.33%

Buy

16.67%

Hold

0.00%

Sell

Based on 12 analysts, 83.33333333333334% of analysts recommend a 'BUY' rating for Charles River Labs. Average target price of $281

Charles River Labs Share Price Target

Get share price movements and forecasts by analysts on Charles River Labs.

What analysts predicted

2.85%UPSIDE

Target Price

$281

Current Price

$273

Analyzed by

12 Analysts

Target

$281.00

Charles River Labs target price $281, a slight upside of 2.85% compared to current price of $273. According to 12 analysts rating.

Indian Investors' Interest in Charles River Labs Stock

Search interest for Charles River Labs Stock has increased by 50% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:50% versus previous 30 day period

Charles River Labs Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
1,011
1,026
1,009
1,002
984
1,032
1,004
994
995
1,004
Gross Profit
344
353
349
284
317
357
338
307
279
363
Operating Income
125
151
117
-167
74
100
133
120
119
119
EBITDA
219
238
209
-86
184
220
197
-192
63
150
Interest Expense
35
32
30
28
27
29
25
23
26
30
Depreciation
85
86
88
102
120
119
85
78
67
67
Income Before Tax
99
119
91
-216
35
71
87
-294
-29
53
Income Tax Expense
24
25
20
-3
10
18
31
-17
-15
53
Net Income
67
89
68
-215
25
52
54
-276
-14
-1
Net Profit Margin
6.66%
8.77%
6.80%
-21.52%
2.59%
5.07%
5.42%
-27.82%
-1.49%
-0.15%

Charles River Labs Annual Profit & Loss

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
1,681
1,857
2,266
2,621
2,923
3,540
3,976
4,129
4,049
4,015
Gross Profit
643
700
840
958
1,073
1,334
1,462
1,502
1,331
1,225
Operating Income
237
288
331
351
432
589
650
617
227
507
EBITDA
377
457
507
563
768
820
986
1,032
581
410
Interest Expense
27
29
63
60
86
73
59
136
126
107
Depreciation
-
131
161
198
234
265
303
311
361
403
Income Before Tax
222
296
281
304
447
480
622
581
93
-99
Income Tax Expense
66
171
54
50
81
81
130
100
67
42
Net Income
154
123
226
252
364
390
486
474
10
-144
Net Profit Margin
9.20%
6.64%
9.99%
9.61%
12.46%
11.04%
12.23%
11.49%
0.25%
-3.59%

Charles River Labs Quarterly Cash Flow

All numbers in Millions USD

Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
94
70
-213
25
52
55
-276
-14
0
Operating Cash Flow
193
251
159
171
204
213
147
41
179
Investing Cash Flow
-61
-21
-76
-45
-37
-33
-73
-407
28
Financing Cash Flow
-285
-207
-75
-105
-226
-152
-51
347
-164
Change in Cash
-157
30
-6
26
-46
24
6
-17
42

Charles River Labs Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
125
227
254
365
398
492
480
25
-142
Operating Cash Flow
316
441
480
546
760
619
683
734
737
Investing Cash Flow
-72
-955
-681
-601
-1,437
-607
-563
-245
-209
Financing Cash Flow
-208
558
231
47
672
-42
-85
-550
-536
Change in Cash
46
30
42
-6
13
-5
43
-78
10

Mutual Funds that own Charles River Labs Stock

Check out the Mutual Funds with significant holdings in Charles River Labs.

Funds
Holdings
Shares Held
VANGUARD INDEX FUNDS
9.792748%
4674948
Fidelity Contrafund
3.502275%
1671947
HARRIS ASSOCIATES INVESTMENT TRUST
3.443315%
1643800
ALLSPRING FUNDS TRUST
3.293948%
1572494
AIM Sector Funds (Invesco Sector Funds)
2.304189%
1099994

Global Institutional Holdings in Charles River Labs

Funds
Holdings
Vanguard
10.37%
iShares
5.1%
SPDR
4.03%
John Rogers
3.16%
Invesco
2.95%

Charles River Labs News & Key Events

  • img

    Today's Timeline - 08 September

    Tue, 05:30 PM

    -

    Charles River Laboratories implements Endosafe Cartridge Technology, enhancing production capacity and efficiency in bacterial endotoxin testing.

    Tue, 07:30 PM

    -

    FMR reports a 10.2% stake in Charles River Laboratories, with no other significant shareholders exceeding 5%.

Insights on Charles River Labs

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 3 quarters, -276.55M → -1.48M (in $), with an average increase of 1332.4% per quarter

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 3 quarters, 994.22M → 1.00B (in $), with an average increase of 0.5% per quarter

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 3 months, CRL stock has moved up by 45.2%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Natera, Inc. Common Stock has given 497.4% return, outperforming this stock by 460.7%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Natera, Inc. Common Stock has given 87.6% return, outperforming this stock by 16.7%

About Charles River Labs

Charles River Laboratories International, Inc. provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. The Research Models and Services segment produces and sells rodents, and purpose-bred rats and mice for use by researchers. This segment also provides a range of services to assist its clients in supporting the use of research models in research and screening pre-clinical drug candidates, including genetically engineered models and services, insourcing solutions, and research animal diagnostic services; and engages in development and production of cell therapies. The Discovery and Safety Assessment segment offers in vitro and in vivo discovery services for the discovery, development, and safety testing of novel drugs, molecule compounds, oligonucleotides, and biotherapeutics, and antibodies through delivery of preclinical drug and therapeutic candidates ready for safety assessment; safety assessment services, such as toxicology, pathology, safety pharmacology, bioanalysis, drug metabolism, and pharmacokinetics services; and vivarium space services. The Manufacturing Solutions segment provides in vitro methods for conventional and rapid quality control testing of sterile and non-sterile pharmaceuticals and consumer products; offers specialized testing of biologics that are outsourced by pharmaceutical and biotechnology companies; and contract development and manufacturing products and services. The company has strategic collaborations with Parker Institute for Cancer Immunotherapy and Children's Hospital Los Angeles across its contract development and manufacturing organization; and Medigen Vaccine Biologics Corp for developing next-generation multivalent enterovirus vaccine, enhance global regulatory readiness, and support IND-enabling non-clinical studies. Additionally, it has a strategic alliance with Francis Crick Institute (Crick), Inc. for the development of Antibody-Drug Conjugate (ADC) drug discovery and de
OrganisationCharles River Labs
Headquarters251 Ballardvale Street, Wilmington, MA, United States, 01887
IndustryDiagnostics & Research
CEOMs. Birgit Girshick
E-voting on sharesClick here to vote

Key Management of Charles River Labs

Name

Title

Ms. Kerry Dailey

Corporate Senior VP & Chief Legal Officer

Dr. Brian F. Bathgate Ph.D.

Corporate Senior Vice President of European Safety Assessment

Mr. Joseph W. LaPlume J.D.

Corporate Executive Vice President of Corporate Development & Strategy

Ms. Victoria L. Creamer

Corporate Executive VP & Chief People Officer

Mr. Glenn G. Coleman CPA

Corporate Executive VP & CFO

Mr. Todd Spencer

Corporate Vice President of Investor Relations

Ms. Birgit Girshick

CEO & Director

Mr. Michael Gunnar Knell

Corporate Senior VP & Chief Accounting Officer

Mr. Mark Mintz

Corporate EVP, Chief Information Officer & Global Shared Services

Ms. Amy E. Cianciaruso

Corporate Senior Vice President, Chief Communications Officer & Government Relations

FAQs

What is Charles River Labs share price today?

Charles River Labs share price today is $273.00 as on at the close of the market. Charles River Labs share today touched a day high of $275.88 and a low of $272.06.

What is the 52 week high and 52 week low for Charles River Labs share?

Charles River Labs share touched a 52 week high of $303.31 on and a 52 week low of $144.26 on . Charles River Labs stock price today i.e. is closed at $273.00,which is 9.99% down from its 52 week high and 89.24% up from its 52 week low.

What is Charles River Labs's market capitalisation today?

Charles River Labs market capitalisation is $0.01T as on .

How to invest in Charles River Labs Stock (CRL) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Charles River Labs on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Charles River Labs Shares that will get you 0.0055 shares as per Charles River Labs share price of $273.00 per share as on September 11, 2026 at 8:45 am IST.

What is the minimum amount required to buy Charles River Labs Stock (CRL) from India?

Indian investors can start investing in Charles River Labs (CRL) shares with as little as ₹95.43 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹954.30 in Charles River Labs stock (as per the Rupee-Dollar exchange rate as on ). Based on Charles River Labs share’s latest price of $273.00 as on September 11, 2026 at 8:45 am IST, you will get 0.0366 shares of Charles River Labs. Learn more about fractional shares .

What are the returns that Charles River Labs has given to Indian investors in the last 5 years?

Charles River Labs stock has given -36.88% share price returns and 28.51% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?